CN112263628A - Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof - Google Patents
Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof Download PDFInfo
- Publication number
- CN112263628A CN112263628A CN202011463683.6A CN202011463683A CN112263628A CN 112263628 A CN112263628 A CN 112263628A CN 202011463683 A CN202011463683 A CN 202011463683A CN 112263628 A CN112263628 A CN 112263628A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- tea
- liupu tea
- liupu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 12
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 11
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title claims abstract description 7
- 230000008569 process Effects 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title abstract description 8
- 240000008672 Gynura procumbens Species 0.000 claims abstract description 11
- 235000018457 Gynura procumbens Nutrition 0.000 claims abstract description 11
- 241001646828 Platostoma chinense Species 0.000 claims abstract description 6
- 241001122767 Theaceae Species 0.000 claims description 57
- 239000000843 powder Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 8
- 240000008027 Akebia quinata Species 0.000 claims description 7
- 235000007756 Akebia quinata Nutrition 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 241000203383 Schefflera Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000643 oven drying Methods 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims 2
- 230000036772 blood pressure Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 241000411851 herbal medicine Species 0.000 abstract description 5
- 241000282414 Homo sapiens Species 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 206010059866 Drug resistance Diseases 0.000 abstract description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract description 2
- 201000001431 Hyperuricemia Diseases 0.000 abstract description 2
- 230000009977 dual effect Effects 0.000 abstract description 2
- 230000002427 irreversible effect Effects 0.000 abstract description 2
- 230000003907 kidney function Effects 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 3
- 235000013616 tea Nutrition 0.000 description 44
- 241001065361 Gynostemma Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 238000000275 quality assurance Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010053649 Vascular rupture Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000019667 acute articular rheumatism Diseases 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention discloses a medicine for preventing and treating hypertension, hyperlipidemia and hyperglycemia prepared from Qingqian Liupu tea, Xia Liupu tea, autumn Liupu tea, herba Gynostemmatis, Mesona chinensis and Gynura procumbens and a process thereof. The five highs are hypertension, hyperlipidemia, hyperglycemia, hypercholesterolemia and hyperuricemia, which are 'rich diseases' derived from modern civilization, and can exist independently or be related to each other. In the face of the problems, western medicine often needs to take chemical medicines for a lifetime, the chemical medicines can cause irreversible damage to the liver and kidney functions of a human body, the treatment period is long, the treatment cost is high, and meanwhile most of the chemical medicines have drug resistance. The Chinese herbal medicine which can be used as both medicine and food for preventing and treating the five highs has the characteristics of small side effect, low price, substantial treatment effect and the like, and is used for treating the five highs fundamentally. The invention selects Chinese herbal medicines with dual purposes of medicine and food as raw materials, and develops the medicine for reducing the five highs without toxic and side effects and with good effect according to the therapeutic principle of overall balance of monarch, minister, assistant and guide in traditional Chinese medicine.
Description
Technical Field
The invention relates to a medicine for reducing hypertension, hyperglycemia and hyperlipidemia and a process thereof, belonging to the field of medicine and health care.
Background
With the improvement of the living standard of residents in China and the change of the dietary structure, the appearance of various foods such as high-protein, high-fat and high-energy beverages, fast food and the like, the popularization of networks, the intelligentization of mobile phones, the lack of reasonable exercise of people, the increase of working pressure and irregular working and rest time, the excess of physical energy and the formation of obesity are caused, and the direct harm caused by the obesity is fat accumulation, endocrine disturbance and the formation of 'five high'. The five highs are hypertension, hyperlipidemia, hyperglycemia, hypercholesterolemia and hyperuricemia, which are 'rich diseases' derived from modern civilization, and can exist independently or be related to each other. Hypertension can cause cerebral hemorrhage and cerebral vascular rupture; hyperlipidemia can cause vascular embolism; hyperglycemia can cause diabetes; high cholesterol can cause diseases such as cerebral atherosclerosis, thrombus and the like; high uric acid can cause gout and easily affect kidney and cardiovascular and cerebrovascular systems. Cardiovascular and cerebrovascular diseases caused by hypertension, hyperlipidemia and the like seriously threaten the physical and psychological health of human beings, and the five highs become health problems which puzzle most of middle-aged and elderly people.
In the face of the problems, western medicine often needs to take chemical medicines for a lifetime, the chemical medicines can cause irreversible damage to the liver and kidney functions of a human body, the treatment period is long, the treatment cost is high, and meanwhile most of the chemical medicines have drug resistance. The Chinese herbal medicine which can be used as both medicine and food for preventing and treating the five highs has the characteristics of small side effect, low price, substantial treatment effect and the like, and is used for treating the five highs fundamentally. The invention selects Chinese herbal medicines with dual purposes of medicine and food as raw materials, and develops the medicine for reducing the five highs without toxic and side effects and with good effect according to the therapeutic principle of overall balance of monarch, minister, assistant and guide in traditional Chinese medicine.
Disclosure of Invention
The invention aims to provide a medicine for reducing five highs and a process thereof, the medicine has the advantages of quality assurance, treatment effect, economy and practicability, and obvious improvement and rehabilitation effect on cardiovascular and cerebrovascular diseases caused by the five highs.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows: the medicine for reducing hypertension, hyperlipidemia and hyperglycemia is characterized by being prepared from Qingqian Liupu tea, Xia Liupu tea, autumn Liupu tea, herba Gynostemmatis, Mesona chinensis and Gynura procumbens.
Preferably, the medicine for reducing "wugao" in the invention is characterized in that the medicine for reducing "wugao" comprises the following components in parts by mass: 2-4 parts of Qingqian Liupu tea, 2-4 parts of summer Liupu tea, 3-7 parts of autumn Liupu tea, 8-13 parts of fiveleaf gynostemma herb, 2-5 parts of sianchau and 2-6 parts of gynura procumbens.
Preferably, the medicine for reducing "wugao" in the invention is characterized in that the medicine for reducing "wugao" comprises the following components in parts by mass: 3 parts of Qingqian Liupu tea, 3 parts of summer Liupu tea, 5 parts of autumn Liupu tea, 10 parts of fiveleaf gynostemma herb, 3 parts of sianchau and 4 parts of gynura procumbens.
Specifically, the raw materials in the invention have the following effects:
the Qingqian Liupu tea has the functions of resisting aging, inhibiting diseases, resisting viruses, reducing blood fat, relieving fatigue and the like.
The Xia Liupao tea has the functions of refreshing, eliminating fatigue, promoting the production of body fluid, clearing heat, promoting urination, nourishing and protecting the stomach and relaxing blood vessels.
The autumn Liupao tea has the functions of cooling, relieving fever, warming stomach, refreshing, removing dampness, regulating qi, strengthening spleen and promoting digestion. Can be used for treating heatstroke, common cold, vomit and stomachache, and removing greasy.
Gynostemma pentaphylla is bitter in taste and cold in nature. Has the functions of diminishing inflammation, detoxicating, relieving cough and eliminating phlegm. Is used for reducing blood fat, reducing blood sugar, resisting tumor, resisting aging, protecting liver, and enhancing immunity.
Gynura procumbens is sweet, bland and flat in taste. Has the functions of clearing away heat and toxic material, dredging meridian passage, diminishing inflammation, relieving cough, eliminating blood stasis, eliminating swelling, promoting blood circulation and promoting granulation. Is mainly used for treating traumatic injury, rheumatic arthralgia and gout, and can improve human immunity and antiviral ability.
Xiancao is sweet, bland and cool in flavor. Has the functions of clearing away heat, promoting diuresis, cooling blood and relieving summer heat. Can be used for treating acute rheumatic arthritis, hypertension, heatstroke, common cold, jaundice, acute nephritis, and diabetes.
The invention also discloses a process for preparing the medicine for reducing the five highs, which comprises the following main steps:
(1) mixing the Liupu tea before cleaning, the Xia Liupu tea and the autumn Liupu tea, then crushing, and sieving with a 10-mesh sieve for later use;
(2) crushing the scandent schefflera into coarse powder, and sieving the coarse powder by a sieve with 10 meshes for later use;
(3) decocting Notoginseng radix and herba mesonae chinensis with water for 2 times, adding 7 times of water for 2 hr for the first time, adding 5 times of water for the second time, decocting for 1.5 hr, filtering, mixing filtrates, concentrating under reduced pressure to density of 1.25-1.20 (about 70 deg.C), and collecting fluid extract;
(4) mixing the above coarse powder, herba Gynostemmatis coarse powder and fluid extract, and oven drying in a drying oven at a temperature below 80 deg.C;
(5) and (3) filling the dried materials into a special filter paper bag for making tea, and then packaging by using a composite film bag to obtain the tea.
Preferably, the process of the medicine for reducing the height of five-highs is characterized in that products with different specifications can be prepared according to market demands.
The invention has the beneficial effects that:
(1) the raw materials of the product are medicinal and edible Chinese herbal medicines, so that the product has the advantages of quality assurance, treatment effect, economy and practicability, and obvious improvement and rehabilitation curative effects on cardiovascular and cerebrovascular diseases caused by hypertension, hyperlipidemia and hyperglycemia.
(2) Based on the consideration of the five-high overall control, the invention mixes a plurality of components to achieve synergistic effect, and can carry out overall treatment.
(3) The Liupao tea belongs to the middle-temperature tea, has the common health-care effects of other teas, has the effects of clearing heat, moistening lung, relieving summer heat, eliminating dampness, improving eyesight, clearing away heart-fire, helping digestion, eliminating stagnation and removing food retention, can help digestion after being eaten, and can clear intestines and stomach after being drunk on an empty stomach.
(4) Meanwhile, the packaging bag can be made into different specifications and packaging modes according to personal habits and market requirements.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The formula is as follows: 3 parts of Qingqian Liupu tea, 3 parts of Xia Liupu tea, 5 parts of autumn Liupu tea, 10 parts of fiveleaf gynostemma herb, 3 parts of Mesona chinensis and 4 parts of Gynura procumbens
The preparation method comprises the following steps: (1) mixing the Liupu tea before cleaning, the Xia Liupu tea and the autumn Liupu tea, then crushing, and sieving with a 10-mesh sieve for later use;
(2) crushing the scandent schefflera into coarse powder, and sieving the coarse powder by a sieve with 10 meshes for later use;
(3) decocting Notoginseng radix and herba mesonae chinensis with water for 2 times, adding 7 times of water for 2 hr for the first time, adding 5 times of water for the second time, decocting for 1.5 hr, filtering, mixing filtrates, concentrating under reduced pressure to density of 1.25-1.20 (about 70 deg.C), and collecting fluid extract;
(4) mixing the above coarse powder, herba Gynostemmatis coarse powder and fluid extract, and oven drying in a drying oven at a temperature below 80 deg.C;
(5) and (3) filling the dried materials into a special filter paper bag for making tea, and then packaging by using a composite film bag to obtain the tea.
Example 2
The formula is as follows: 2 parts of Qingqian Liupu tea, 2 parts of Xia Liupu tea, 3 parts of autumn Liupu tea, 8 parts of fiveleaf gynostemma herb, 2 parts of Mesona chinensis and 2 parts of Gynura procumbens
The preparation method comprises the following steps: (1) mixing the Liupu tea before cleaning, the Xia Liupu tea and the autumn Liupu tea, then crushing, and sieving with a 10-mesh sieve for later use;
(2) crushing the scandent schefflera into coarse powder, and sieving the coarse powder by a sieve with 10 meshes for later use;
(3) decocting Notoginseng radix and herba mesonae chinensis with water for 2 times, adding 7 times of water for 2 hr for the first time, adding 5 times of water for the second time, decocting for 1.5 hr, filtering, mixing filtrates, concentrating under reduced pressure to density of 1.25-1.20 (about 70 deg.C), and collecting fluid extract;
(4) mixing the above coarse powder, herba Gynostemmatis coarse powder and fluid extract, and oven drying in a drying oven at a temperature below 80 deg.C;
(5) and (3) filling the dried materials into a special filter paper bag for making tea, and then packaging by using a composite film bag to obtain the tea.
Example 3
The formula is as follows: 4 parts of Qingqian Liupu tea, 4 parts of Xia Liupu tea, 7 parts of autumn Liupu tea, 13 parts of fiveleaf gynostemma herb, 5 parts of Mesona chinensis and 6 parts of Gynura procumbens
The preparation method comprises the following steps: (1) mixing the Liupu tea before cleaning, the Xia Liupu tea and the autumn Liupu tea, then crushing, and sieving with a 10-mesh sieve for later use;
(2) crushing the scandent schefflera into coarse powder, and sieving the coarse powder by a sieve with 10 meshes for later use;
(3) decocting Notoginseng radix and herba mesonae chinensis with water for 2 times, adding 7 times of water for 2 hr for the first time, adding 5 times of water for the second time, decocting for 1.5 hr, filtering, mixing filtrates, concentrating under reduced pressure to density of 1.25-1.20 (about 70 deg.C), and collecting fluid extract;
(4) mixing the above coarse powder, herba Gynostemmatis coarse powder and fluid extract, and oven drying in a drying oven at a temperature below 80 deg.C;
(5) and (3) filling the dried materials into a special filter paper bag for making tea, and then packaging by using a composite film bag to obtain the tea.
The above-mentioned serial numbers of the embodiments of the present invention are merely for description and do not represent the merits of the embodiments.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (5)
1. A medicine for reducing hypertension, hyperlipidemia and hyperglycemia is characterized by being prepared from Qingqian Liupu tea, Xia Liupu tea, autumn Liupu tea, herba Gynostemmatis, Mesona chinensis and Gynura procumbens.
2. The medicine for reducing the five highs according to claim 1, which is characterized in that the components and parts by mass of the medicine for reducing the five highs are as follows: 2-4 parts of Qingqian Liupu tea, 2-4 parts of summer Liupu tea, 3-7 parts of autumn Liupu tea, 8-13 parts of fiveleaf gynostemma herb, 2-5 parts of sianchau and 2-6 parts of gynura procumbens.
3. The medicine for reducing the five highs according to claim 2, which is characterized by comprising the following components in parts by mass: 3 parts of Qingqian Liupu tea, 3 parts of summer Liupu tea, 5 parts of autumn Liupu tea, 10 parts of fiveleaf gynostemma herb, 3 parts of sianchau and 4 parts of gynura procumbens.
4. The process for preparing a medicine for reducing the blood pressure, the blood fat and the blood sugar of any one of claims 1 to 3, which is characterized by comprising the following main steps:
(1) mixing the Liupu tea before cleaning, the Xia Liupu tea and the autumn Liupu tea, then crushing, and sieving with a 10-mesh sieve for later use;
(2) crushing the scandent schefflera into coarse powder, and sieving the coarse powder by a sieve with 10 meshes for later use;
(3) decocting Notoginseng radix and herba mesonae chinensis with water for 2 times, adding 7 times of water for 2 hr for the first time, adding 5 times of water for the second time, decocting for 1.5 hr, filtering, mixing filtrates, concentrating under reduced pressure to density of 1.25-1.20 (about 70 deg.C), and collecting fluid extract;
(4) mixing the above coarse powder, herba Gynostemmatis coarse powder and fluid extract, and oven drying in a drying oven at a temperature below 80 deg.C;
(5) and (3) filling the dried materials into a special filter paper bag for making tea, and then packaging by using a composite film bag to obtain the tea.
5. The process of claim 4, wherein the product is prepared into different specifications according to market demand.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011463683.6A CN112263628A (en) | 2020-12-15 | 2020-12-15 | Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011463683.6A CN112263628A (en) | 2020-12-15 | 2020-12-15 | Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112263628A true CN112263628A (en) | 2021-01-26 |
Family
ID=74350071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011463683.6A Pending CN112263628A (en) | 2020-12-15 | 2020-12-15 | Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112263628A (en) |
-
2020
- 2020-12-15 CN CN202011463683.6A patent/CN112263628A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1227728A (en) | Flavouring nutritive health food capable of refreshing oneself, relieving summer heat and curing disease | |
| CN103385508B (en) | Traditional Chinese medicine healthcare beverage with functions of dispelling cold and moistening dryness and preparation method thereof | |
| CN101168710B (en) | Eucommia bark wine and preparation method thereof | |
| CN112603971B (en) | Cordyceps militaris and pericarpium citri reticulatae traditional Chinese medicine composition, preparation method and application thereof | |
| CN102366604A (en) | Sobering traditional Chinese medicinal preparation and its preparation method | |
| CN106035860A (en) | Health-preserving bagged tea capable of reducing weight and reducing blood pressure and preparation method of health-preserving bagged tea | |
| CN106806740A (en) | A kind of composition with nourishing the stomach is calmed the nerves function and preparation method thereof | |
| CN107874203A (en) | A kind of preparation method of jujube yam health care jelly | |
| CN111758874A (en) | Health-preserving solid beverage for conditioning qi and blood states and preparation method thereof | |
| CN106234690A (en) | A kind of health-care bagged tea and preparation method thereof | |
| CN109758561A (en) | It is a kind of for treating the Chinese materia medica preparation and preparation method thereof of obstinate type sleep disturbance | |
| CN106173014A (en) | A kind of bitter leaves tea beverage of promoting the production of body fluid to quench thirst and preparation method thereof | |
| CN112263628A (en) | Medicine for reducing hypertension, hyperglycemia and hyperlipidemia and process thereof | |
| CN104855612A (en) | Dendrobium-Chinese wolfberry life-preserving traditional Chinese medicine tea beverage and preparation method | |
| CN112493387A (en) | Millettia speciosa champ solid beverage particles with anti-fatigue effect and preparation process thereof | |
| CN103721127A (en) | Beauty and sliming tea and preparation method thereof | |
| CN105998639A (en) | Oral liquid with lipid-decreasing and pressure-decreasing effects and preparation method thereof | |
| CN111034966A (en) | Preparation method of ginseng absorbable jelly with liver protection function | |
| CN111011852A (en) | Preparation method of ginseng instant food with liver protection function | |
| CN104351389A (en) | Malt and hawthorn herbal tea drink with function of health maintenance, and preparation method of malt and hawthorn herbal tea drink | |
| CN106798044A (en) | A kind of Radix Codonopsis tonifying middle-Jiao and Qi fruity tea cream and preparation method thereof | |
| CN106165749A (en) | One treats deficient qi and blood anemia medicated tea and preparation processing method | |
| CN106234671A (en) | Maize health preserving Tea containing traditional Chinese medicine beverage and preparation method | |
| CN105497604A (en) | Traditional Chinese medicine composition tea capable of dispelling effect of alcohol | |
| CN106538904A (en) | A kind of relieved beverage of blood circulation promoting and blood stasis dispelling qi-regulating and preparation processing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210126 |